Help for families struggling with YTD may soon be on the way . At last month ' s annual AMA Convention , Smithkline Beecham unveiled Juvenol , a promising YTD drug which , pending FDA approval , could reach the U . S . market as early as next spring . Already available in France and Sweden , Juvenol , the Swedish newspaper Aftonbladet reported , resulted in a 60 percent decrease in running and jumping among users .
